These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1281426

  • 1. Identification of functional arginines in human angiogenin by site-directed mutagenesis.
    Shapiro R, Vallee BL.
    Biochemistry; 1992 Dec 15; 31(49):12477-85. PubMed ID: 1281426
    [Abstract] [Full Text] [Related]

  • 2. Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis.
    Shapiro R, Fox EA, Riordan JF.
    Biochemistry; 1989 Feb 21; 28(4):1726-32. PubMed ID: 2497770
    [Abstract] [Full Text] [Related]

  • 3. Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogenin.
    Hallahan TW, Shapiro R, Strydom DJ, Vallee BL.
    Biochemistry; 1992 Sep 01; 31(34):8022-9. PubMed ID: 1380830
    [Abstract] [Full Text] [Related]

  • 4. Mutagenesis of residues flanking Lys-40 enhances the enzymatic activity and reduces the angiogenic potency of angiogenin.
    Harper JW, Fox EA, Shapiro R, Vallee BL.
    Biochemistry; 1990 Aug 07; 29(31):7297-302. PubMed ID: 1698454
    [Abstract] [Full Text] [Related]

  • 5. Dual site model for the organogenic activity of angiogenin.
    Hallahan TW, Shapiro R, Vallee BL.
    Proc Natl Acad Sci U S A; 1991 Mar 15; 88(6):2222-6. PubMed ID: 2006161
    [Abstract] [Full Text] [Related]

  • 6. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis.
    Shapiro R, Vallee BL.
    Biochemistry; 1989 Sep 05; 28(18):7401-8. PubMed ID: 2479414
    [Abstract] [Full Text] [Related]

  • 7. Role of glutamine-117 in the ribonucleolytic activity of human angiogenin.
    Russo N, Shapiro R, Acharya KR, Riordan JF, Vallee BL.
    Proc Natl Acad Sci U S A; 1994 Apr 12; 91(8):2920-4. PubMed ID: 8159680
    [Abstract] [Full Text] [Related]

  • 8. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth.
    Leonidas DD, Shapiro R, Allen SC, Subbarao GV, Veluraja K, Acharya KR.
    J Mol Biol; 1999 Jan 22; 285(3):1209-33. PubMed ID: 9918722
    [Abstract] [Full Text] [Related]

  • 9. Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogenin.
    Harper JW, Vallee BL.
    Proc Natl Acad Sci U S A; 1988 Oct 22; 85(19):7139-43. PubMed ID: 2459697
    [Abstract] [Full Text] [Related]

  • 10. A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis.
    Harper JW, Vallee BL.
    Biochemistry; 1989 Feb 21; 28(4):1875-84. PubMed ID: 2719939
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the activity of angiogenin by mutagenesis at Asp-116.
    Curran TP, Shapiro R, Riordan JF, Vallee BL.
    Biochim Biophys Acta; 1993 Oct 06; 1202(2):281-6. PubMed ID: 7691185
    [Abstract] [Full Text] [Related]

  • 12. Alteration of the enzymatic specificity of human angiogenin by site-directed mutagenesis.
    Curran TP, Shapiro R, Riordan JF.
    Biochemistry; 1993 Mar 09; 32(9):2307-13. PubMed ID: 8095159
    [Abstract] [Full Text] [Related]

  • 13. Enzymatically active angiogenin/ribonuclease A hybrids formed by peptide interchange.
    Harper JW, Auld DS, Riordan JF, Vallee BL.
    Biochemistry; 1988 Jan 12; 27(1):219-26. PubMed ID: 3349027
    [Abstract] [Full Text] [Related]

  • 14. Replacement of residues 8-22 of angiogenin with 7-21 of RNase A selectively affects protein synthesis inhibition and angiogenesis.
    Bond MD, Vallee BL.
    Biochemistry; 1990 Apr 03; 29(13):3341-9. PubMed ID: 1692238
    [Abstract] [Full Text] [Related]

  • 15. Characterization of mouse angiogenin-related protein: implications for functional studies on angiogenin.
    Nobile V, Vallee BL, Shapiro R.
    Proc Natl Acad Sci U S A; 1996 Apr 30; 93(9):4331-5. PubMed ID: 8633065
    [Abstract] [Full Text] [Related]

  • 16. Kinetic characterization of two active mutants of placental ribonuclease inhibitor that lack internal repeats.
    Lee FS, Vallee BL.
    Biochemistry; 1990 Jul 17; 29(28):6633-8. PubMed ID: 2397204
    [Abstract] [Full Text] [Related]

  • 17. The C-terminal region of human angiogenin has a dual role in enzymatic activity.
    Russo N, Nobile V, Di Donato A, Riordan JF, Vallee BL.
    Proc Natl Acad Sci U S A; 1996 Apr 16; 93(8):3243-7. PubMed ID: 8622921
    [Abstract] [Full Text] [Related]

  • 18. A monoclonal antibody to human angiogenin. Inhibition of ribonucleolytic and angiogenic activities and localization of the antigenic epitope.
    Fett JW, Olson KA, Rybak SM.
    Biochemistry; 1994 May 10; 33(18):5421-7. PubMed ID: 7514035
    [Abstract] [Full Text] [Related]

  • 19. Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues.
    Shapiro R, Weremowicz S, Riordan JF, Vallee BL.
    Proc Natl Acad Sci U S A; 1987 Dec 10; 84(24):8783-7. PubMed ID: 3122207
    [Abstract] [Full Text] [Related]

  • 20. Kinetic, stereochemical, and structural effects of mutations of the active site arginine residues in 4-oxalocrotonate tautomerase.
    Harris TK, Czerwinski RM, Johnson WH, Legler PM, Abeygunawardana C, Massiah MA, Stivers JT, Whitman CP, Mildvan AS.
    Biochemistry; 1999 Sep 21; 38(38):12343-57. PubMed ID: 10493802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.